Avandia and Conduction disorder - a phase IV clinical study of FDA data

Summary:

Conduction disorder is reported as a side effect among people who take Avandia (rosiglitazone maleate), especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years also take Lasix, and have Hiv infection.

The phase IV clinical study analyzes which people have Conduction disorder when taking Avandia. It is created by eHealthMe based on reports of 141,991 people who have side effects when taking Avandia from the FDA, and is updated regularly.

What is Avandia?

Avandia has active ingredients of rosiglitazone maleate. It is often used in diabetes. eHealthMe is studying from 142,155 Avandia users. Check the latest studies of Avandia.

What is Conduction disorder?

Conduction disorder (serious disorder of the heart not responses proper to impulses) is found to be associated with 284 drugs and 445 conditions by eHealthMe. Check the latest studies of Conduction disorder.

On Jul, 07, 2026

141,991 people reported to have side effects when taking Avandia.
Among them, 32 people (0.02%) have Conduction disorder.

Could Avandia cause Conduction disorder?

Among these 32 people:

How long have people been on Avandia when they have Conduction disorder? *

What is the gender of people who have Conduction disorder when taking Avandia? *

female: 34.38 %
male: 65.62 %

What is the age of people who have Conduction disorder when taking Avandia? *

What are other drugs people take besides Avandia? *

What are other side effects people have besides Conduction disorder? *

Heart Attack: 18 people, 56.25%
Cardiac Failure Congestive: 17 people, 53.12%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 31.25%
Stress And Anxiety: 9 people, 28.12%
Acute Kidney Failure: 8 people, 25.00%
Oedema Peripheral (superficial swelling): 8 people, 25.00%
Pleural Effusion (water on the lungs): 7 people, 21.88%
Mitral Valve Incompetence (inefficient heart valve): 7 people, 21.88%
Atrioventricular Block First Degree (heart block first degree): 7 people, 21.88%
Pain: 7 people, 21.88%

What are the existing conditions these people have? *

Hiv Infection: 4 people, 12.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.25%
Pain: 1 person, 3.12%
Nausea And Vomiting: 1 person, 3.12%
Metastases To Bone (cancer spreads to bone): 1 person, 3.12%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 3.12%
Impaired Gastric Emptying: 1 person, 3.12%
Ill-Defined Disorder: 1 person, 3.12%
High Blood Pressure: 1 person, 3.12%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Avandia and have Conduction disorder?

- Check whether Conduction disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avandia:

Avandia (142,155 reports)

Browse all side effects of Avandia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conduction disorder:

Conduction disorder (284 drugs)

Browse all the conditions that are associated with Conduction disorder:

Conduction disorder (445 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosiglitazone maleate (the active ingredients of Avandia) and Avandia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.